Perioperative Blood Transfusion in Open Liver Resection
NCT ID: NCT06189911
Last Updated: 2024-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1201 participants
OBSERVATIONAL
2006-01-01
2023-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer are:
1. What are the risk factors of peri-operative blood transfusion in open liver resection procedures
2. What are the difference outcomes between patients who receive blood transfusion and the other group.
Researcher will compare perioperative factor and post operative outcomes between transfused and non-transfused group
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perioperative Blood Transfusion and Increased One-year Mortality
NCT07094295
Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection
NCT06905015
Intraoperative Estimated Blood Loss, Blood Transfusion, and Postoperative Clinical Outcomes in Patients Undergoing Non Cardiac Surgery, Siriraj Hospital
NCT05430659
Fluid Management Strategies on Blood Loss in Liver Transplantation
NCT06215404
Transfusion Prediction in Major Abdominal Surgery
NCT06847490
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The data was systematically retrieved from electronic medical records. Baseline characteristics including age, gender, body mass index (BMI), co-morbidity, American Society of Anesthesiologists (ASA) classification, diagnosis, hepatitis profile, Child-Pugh classification, cirrhosis, the largest tumor size, previous liver resection, and pre-operative laboratory investigations were collected.
The following intra-operative data were collected: type of liver resection, hilar resection, vascular reconstruction, volume and type of fluid administration, estimated blood loss, packed red cell and blood product transfusion, and operation time. The definitions of liver resection and the type of hepatectomy were aligned with the anatomic classification of the Brisbane 2000 Terminology
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
transfused
Group of patients who received perioperative blood transfusions which was defined as the transfusion of packed red cells during the operation and 48 hours after surgery.
Open liver resection
The definitions of liver resection and the type of hepatectomy were aligned with the anatomic classification of the Brisbane 2000 Terminology
non-transfused
Group of patients who did not received perioperative blood transfusions
Open liver resection
The definitions of liver resection and the type of hepatectomy were aligned with the anatomic classification of the Brisbane 2000 Terminology
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Open liver resection
The definitions of liver resection and the type of hepatectomy were aligned with the anatomic classification of the Brisbane 2000 Terminology
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective open liver resection
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chiang Mai University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Warangkana Lapisatepun
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Warangkana Lapisatepun, M.D.
Role: PRINCIPAL_INVESTIGATOR
Chiang Mai University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANE-2564-08020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.